L-Glutamic acid, N-[4-[[ (2-amino-1, 4-dihydro-4-oxo-6-pteridinyl)meth yl]methylamino]benzoyl]-
-
![L-Glutamic acid, N-[4-[[ (2-amino-1, 4-dihydro-4-oxo-6-pteridinyl)meth yl]methylamino]benzoyl]- structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220812/75199fdbddcf4407b235f83ce11a024b.png "L-Glutamic acid, N-[4-[[ (2-amino-1, 4-dihydro-4-oxo-6-pteridinyl)meth yl]methylamino]benzoyl]-")
L-Glutamic acid, N-[4-[[ (2-amino-1, 4-dihydro-4-oxo-6-pteridinyl)meth yl]methylamino]benzoyl]-
structure -
-
CAS No:
2410-93-7
-
Formula:
C20H21N7O6
-
Chemical Name:
L-Glutamic acid, N-[4-[[ (2-amino-1, 4-dihydro-4-oxo-6-pteridinyl)meth yl]methylamino]benzoyl]-
-
Synonyms:
Methotrexate EP Impurity C（Amethopterin EP Impurity C）;Methotrexate-EP-Imp-C;L-Glutamic acid,N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]methylamino]benzoyl]-;Methotrexate EP Impurity C/Methotrextae 4-Oxo Analog/N-Methylfolic acid/(2S)-2-[[4-[[(2-amino-4-hydroxy pteridin-6-yl)methyl]methyl amino] benzoyl]amino]pentanedioic acid;Methotrexate Related CoMpound C;(2S)-2-[[4-[[(2-amino-4-hydroxy pteridin-6-yl) methyl] methyl amino] benzoyl] amino] pentanedioic acid;2-[[4-[(2-Amino-4-Oxo-1H-Pteridin-6-Yl)Methyl-Methylamino]Benzoyl]Amino]Pentanedioic Acid;L-Glutamic acid, N-[4-[[ (2-amino-1, 4-dihydro-4-oxo-6-pteridinyl)meth yl]methylamino]benzoyl]-
- Categories:
-
CAS No:
L-Glutamic acid, N-[4-[[ (2-amino-1, 4-dihydro-4-oxo-6-pteridinyl)meth yl]methylamino]benzoyl]- Basic Attributes
455.42
455.42
9TJY624421
Pale Brown to Brown
2933599550
Characteristics
204.75000
1.36390
1.61±0.1 g/cm3(Predicted)
144 - 150°C
1.732
3.49±0.10(Predicted)
Hygroscopic, -20°C Freezer, Under inert atmosphere
Safety Information
NONH for all modes of transport
WGK 3
P201, P202, P264, P270, P280, P281, P301+P312, P302+P352, P305+P351+P338, P308+P313, P321, P330, P332+P313, P337+P313, P362, P405, P501
H302
UN 2811 6.1 / PGIII
|Warning|H302 (33.33%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P264, P270, P280, P281, P301+P312, P302+P352, P305+P351+P338, P308+P313, P321, P330, P332+P313, P337+P313, P362, P405, and P501|Aggregated GHS information provided by 3 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
L-Glutamic acid, N-[4-[[ (2-amino-1, 4-dihydro-4-oxo-6-pteridinyl)meth yl]methylamino]benzoyl]- Use and Manufacturing
2-[(2-Hydroxy-4,5-dimethoxybenzoyl)amino]-4-thiazolecarboxylic Acid is an impurity of Acotiamide (A190260), an acetylcholinesterase inhibitor which has been shown to stimulate gastric motility and improve gastric motility dysfunction in rats. Acotiamide Hydrochloride has also been shown to improve meal-related symptoms of functional dyspepsia.
Computed Properties
Molecular Weight:455.4
XLogP3:-0.9
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:10
Rotatable Bond Count:9
Exact Mass:455.15533142
Monoisotopic Mass:455.15533142
Topological Polar Surface Area:200
Heavy Atom Count:33
Complexity:798
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
Dibutyl adipate
105-99-7
-
Chloroprene
126-99-8
-
Calcipotriol Monohydrate
147657-22-5
-
Icariin Formula
489-32-7
-
Pteroic acid Formula
119-24-4
-
Piperazine, 1-(3-chlorophenyl)-, hydrochloride (1:?) Formula
65369-76-8
-
2-Butyl-3-(4-hydroxybenzoyl)benzofuran Structure
52490-15-0
-
2-(2-Methoxyphenoxy)ethanamine Structure
1836-62-0
-
What is 2-NP-AHD
623145-57-3
-
What is rel-(4R,4aR,8aS)-Octahydro-4,8a-dimethyl-4a(2H)-naphthalenol
16423-19-1
L-Glutamic acid, N-[4-[[ (2-amino-1, 4-dihydro-4-oxo-6-pteridinyl)meth yl]methylamino]benzoyl]-
SDSRequest for Quotation